Zkusit zdarma
Akebia Therapeutics, Inc.

Akebia Therapeutics, Inc.

AKBA
Cena:
 
 
Valuace
70
Růst
30
Zdraví
60
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Akebia Therapeutics Sees Vafseo Uptake Rising as Access and Pipeline Milestones Near

Akebia Therapeutics Sees Vafseo Uptake Rising as Access and Pipeline Milestones Near

20:05 04-06-2026

Akebia Therapeutics NASDAQ: AKBA outlined its commercial priorities for Vafseo, the expected evoluti...

Akebia Therapeutics, Inc. (AKBA) Q1 2026 Earnings Call Transcript

Akebia Therapeutics, Inc. (AKBA) Q1 2026 Earnings Call Transcript

15:51 07-05-2026

Akebia Therapeutics, Inc. (AKBA) Q1 2026 Earnings Call Transcript...

Akebia Therapeutics (AKBA) Reports Q1 Loss, Misses Revenue Estimates

Akebia Therapeutics (AKBA) Reports Q1 Loss, Misses Revenue Estimates

9:51 07-05-2026

Akebia Therapeutics (AKBA) came out with a quarterly loss of $0.03 per share versus the Zacks Consen...

Akebia Therapeutics Reports First Quarter 2026 Financial Results and Commercial and Pipeline Highlights

Akebia Therapeutics Reports First Quarter 2026 Financial Results and Commercial and Pipeline Highlights

7:00 07-05-2026

Q1 2026 Vafseo® (vadadustat) net product revenues grew to  $15.8 million ; Q1 2026 total net produ...

Akebia Therapeutics Announces Vadadustat Post-hoc Win Statistics Analysis Demonstrating Statistically Significant Reduction in Mortality and Hospitalization Composite Endpoint Published in the Journal of American Society of Nephrology

Akebia Therapeutics Announces Vadadustat Post-hoc Win Statistics Analysis Demonstrating Statistically Significant Reduction in Mortality and Hospitalization Composite Endpoint Published in the Journal of American Society of Nephrology

8:00 04-05-2026

CAMBRIDGE, Mass., May 04, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a bio...

Akebia Therapeutics to Report First Quarter 2026 Financial Results and Discuss Recent Business Highlights

Akebia Therapeutics to Report First Quarter 2026 Financial Results and Discuss Recent Business Highlights

16:05 30-04-2026

Akebia to Host Conference Call on May 7 at 8:00 a.m. EDT CAMBRIDGE, Mass....

New Strong Sell Stocks for April 28th

New Strong Sell Stocks for April 28th

5:01 28-04-2026

EADSY, AKBA and AMTB have been added to the Zacks Rank #5 (Strong Sell) List on April 28, 2026....

Akebia Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of AKB-9090

Akebia Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of AKB-9090

8:00 13-04-2026

CAMBRIDGE, Mass., April 13, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a...

Akebia Therapeutics to Conduct Investor Meetings at the Raymond James 2026 Biotech Innovation Symposium

Akebia Therapeutics to Conduct Investor Meetings at the Raymond James 2026 Biotech Innovation Symposium

8:00 07-04-2026

CAMBRIDGE, Mass., April 07, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a...

JPMorgan Chase & Co. Has $2.71 Million Holdings in Akebia Therapeutics, Inc. $AKBA

JPMorgan Chase & Co. Has $2.71 Million Holdings in Akebia Therapeutics, Inc. $AKBA

4:45 06-04-2026

JPMorgan Chase and Co. lessened its holdings in Akebia Therapeutics, Inc. (NASDAQ: AKBA) by 39.8% du...

Akebia Therapeutics R&D Day: Vafseo Growth Plan, Praliciguat Phase 2, New Kidney Pipeline Targets

Akebia Therapeutics R&D Day: Vafseo Growth Plan, Praliciguat Phase 2, New Kidney Pipeline Targets

1:05 04-04-2026

Akebia Therapeutics (NASDAQ: AKBA) used its R&D Day presentation to outline a strategy centered on e...

Akebia Therapeutics, Inc. $AKBA Shares Sold by Assenagon Asset Management S.A.

Akebia Therapeutics, Inc. $AKBA Shares Sold by Assenagon Asset Management S.A.

3:22 03-04-2026

Assenagon Asset Management S.A. cut its stake in Akebia Therapeutics, Inc. (NASDAQ: AKBA) by 94.2% i...

Akebia Therapeutics, Inc. (AKBA) Discusses Pipeline Progress and Strategic Focus on Kidney Disease Treatments at R&D Day Transcript

Akebia Therapeutics, Inc. (AKBA) Discusses Pipeline Progress and Strategic Focus on Kidney Disease Treatments at R&D Day Transcript

16:52 02-04-2026

Akebia Therapeutics, Inc. (AKBA) Discusses Pipeline Progress and Strategic Focus on Kidney Disease T...

Akebia Therapeutics Appoints Biopharmaceutical Leader Philip Vickers, Ph.D. to its Board of Directors

Akebia Therapeutics Appoints Biopharmaceutical Leader Philip Vickers, Ph.D. to its Board of Directors

16:05 01-04-2026

CAMBRIDGE, Mass., April 01, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a...

Akebia Therapeutics to Host Virtual R&D Day Highlighting Robust Kidney Disease Pipeline, on April 2, 2026

Akebia Therapeutics to Host Virtual R&D Day Highlighting Robust Kidney Disease Pipeline, on April 2, 2026

16:05 19-03-2026

CAMBRIDGE, Mass., March 19, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a...

Is the Options Market Predicting a Spike in Akebia Therapeutics Stock?

Is the Options Market Predicting a Spike in Akebia Therapeutics Stock?

10:01 17-03-2026

Investors need to pay close attention to AKBA stock based on the movements in the options market lat...

Akebia Therapeutics, Inc. (AKBA) Presents at Leerink Global Healthcare Conference 2026 Transcript

Akebia Therapeutics, Inc. (AKBA) Presents at Leerink Global Healthcare Conference 2026 Transcript

17:58 09-03-2026

Akebia Therapeutics, Inc. (AKBA) Presents at Leerink Global Healthcare Conference 2026 Transcript...

Akebia Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Discuss Recent Business Highlights

Akebia Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Discuss Recent Business Highlights

8:00 19-02-2026

CAMBRIDGE, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA) today...

Akebia Therapeutics, Inc. (AKBA) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript

Akebia Therapeutics, Inc. (AKBA) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript

16:57 13-02-2026

Akebia Therapeutics, Inc. (AKBA) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit ...

Akebia Therapeutics to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026

Akebia Therapeutics to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026

8:00 04-02-2026

CAMBRIDGE, Mass., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a ...

close

AKEBIA THERAPEUTICS TO PRESENT AT THE GUGGENHEIM EMERGING OUTLOOK: BIOTECH SUMMIT 2026

04-02-2026
CAMBRIDGE, MASS., FEB. 04, 2026 (GLOBE NEWSWIRE) -- AKEBIA THERAPEUTICS ® , INC. (NASDAQ: AKBA), A ...
Více zde

AKEBIA THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

02-02-2026
CAMBRIDGE, MASS., FEB. 02, 2026 (GLOBE NEWSWIRE) -- AKEBIA THERAPEUTICS ® , INC. (NASDAQ: AKBA), A ...
Více zde

AKEBIA THERAPEUTICS ANNOUNCES CORPORATE UPDATES AND 2026 PIPELINE OUTLOOK

12-01-2026
POSITIONED TO INCREASE DEPTH OF VAFSEO PRESCRIBING ENTERING 2026 WITH ACCESS TO APPROXIMATELY 275,00...
Více zde

AKEBIA THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN PHASE 2 CLINICAL TRIAL OF PRALICIGUAT FOR THE TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)

06-01-2026
CAMBRIDGE, MASS., JAN. 06, 2026 (GLOBE NEWSWIRE) -- AKEBIA THERAPEUTICS ® , INC. (NASDAQ: AKBA), A ...
Více zde

AKEBIA THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

05-01-2026
CAMBRIDGE, MASS., JAN. 05, 2026 (GLOBE NEWSWIRE) -- AKEBIA THERAPEUTICS ® , INC. (NASDAQ: AKBA), A ...
Více zde

AKEBIA THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

01-12-2025
CAMBRIDGE, MASS., DEC. 01, 2025 (GLOBE NEWSWIRE) -- AKEBIA THERAPEUTICS ® , INC. (NASDAQ: AKBA), A ...
Více zde

Q32 BIO SELLS COMPLEMENT INHIBITOR ADX-097

01-12-2025
-- ASSET SALE FURTHER ENABLES COMPANY'S STRATEGIC FOCUS ON ADVANCING BEMPIKIBART FOR ALOPECIA AREATA...
Více zde

AKEBIA THERAPEUTICS TO PRESENT AT THE PIPER SANDLER 37TH ANNUAL HEALTHCARE CONFERENCE

24-11-2025
CAMBRIDGE, MASS., NOV. 24, 2025 (GLOBE NEWSWIRE) -- AKEBIA THERAPEUTICS ® , INC. (NASDAQ: AKBA), A ...
Více zde

AKEBIA THERAPEUTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS

10-11-2025
VAFSEO® (VADADUSTAT) Q3 2025 NET PRODUCT REVENUES GREW TO  $14.3 MILLION ; Q3 2025 TOTAL NET PRODU...
Více zde

VAFSEO® (VADADUSTAT) DIALYSIS DEPENDENT PATIENT POST HOC DATA ANALYSIS: COMPOSITE OF ALL-CAUSE MORTALITY AND HOSPITALIZATION OUTCOMES STATISTICALLY MORE FAVORABLE FOR PATIENTS RECEIVING VADADUSTAT VS. ESAS

06-11-2025
WIN-ODDS ANALYSIS PRESENTED AT AMERICAN SOCIETY OF NEPHROLOGY KIDNEY WEEK 2025 WIN-ODDS ANALYSIS PRE...
Více zde

AKEBIA THERAPEUTICS TO PRESENT AT UPCOMING INVESTOR CONFERENCES

04-11-2025
CAMBRIDGE, MASS., NOV. 04, 2025 (GLOBE NEWSWIRE) -- AKEBIA THERAPEUTICS ® , INC. (NASDAQ: AKBA), A ...
Více zde

AKEBIA THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

03-11-2025
CAMBRIDGE, MASS., NOV. 03, 2025 (GLOBE NEWSWIRE) -- AKEBIA THERAPEUTICS ® , INC. (NASDAQ: AKBA), A ...
Více zde

AKEBIA THERAPEUTICS TO REPORT THIRD QUARTER 2025 FINANCIAL RESULTS AND DISCUSS RECENT BUSINESS HIGHLIGHTS

30-10-2025
CAMBRIDGE, MASS., OCT. 30, 2025 (GLOBE NEWSWIRE) -- AKEBIA THERAPEUTICS®, INC. (NASDAQ: AKBA) TODAY...
Více zde

AKEBIA THERAPEUTICS PROVIDES UPDATE ON VAFSEO FOR NON-DIALYSIS PATIENTS

28-10-2025
AKEBIA DOES NOT EXPECT TO INITIATE VALOR CLINICAL TRIAL FOLLOWING TYPE C MEETING FEEDBACK FROM U.S. ...
Více zde

AKEBIA THERAPEUTICS ANNOUNCES FIVE PRESENTATIONS AT ASN KIDNEY WEEK 2025

20-10-2025
PRESENTATIONS DETAIL ONGOING VAFSEO® (VADADUSTAT) REAL-WORLD STUDIES AND EXPLORE INSIGHTS REGARDING...
Více zde

AKEBIA THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

01-10-2025
CAMBRIDGE, MASS., OCT. 01, 2025 (GLOBE NEWSWIRE) -- AKEBIA THERAPEUTICS®, INC. (NASDAQ: AKBA), A BI...
Více zde

AKEBIA THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

02-09-2025
CAMBRIDGE, MASS., SEPT. 02, 2025 (GLOBE NEWSWIRE) -- AKEBIA THERAPEUTICS ® , INC. (NASDAQ: AKBA), A...
Více zde

AKEBIA THERAPEUTICS TO PRESENT AT UPCOMING INVESTOR CONFERENCES

28-08-2025
CAMBRIDGE, MASS., AUG. 28, 2025 (GLOBE NEWSWIRE) -- AKEBIA THERAPEUTICS ® , INC. (NASDAQ: AKBA), A ...
Více zde

AKEBIA THERAPEUTICS AND INNOVATIVE RENAL CARE ANNOUNCE NATIONWIDE AVAILABILITY OF VAFSEO® (VADADUSTAT) ACROSS ALL IRC DIALYSIS CLINICS

21-08-2025
CAMBRIDGE, MASS. AND FRANKLIN, TENN....
Více zde

AKEBIA THERAPEUTICS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS

07-08-2025
CONTINUED VAFSEO® (VADADUSTAT) GROWTH WITH Q2 2025 NET PRODUCT REVENUES INCREASING TO $13.3 MILLION...
Více zde

AKEBIA THERAPEUTICS TO PRESENT AT CANACCORD GENUITY'S 45TH ANNUAL GROWTH CONFERENCE

06-08-2025
CAMBRIDGE, MASS., AUG. 06, 2025 (GLOBE NEWSWIRE) -- AKEBIA THERAPEUTICS ® , INC. (NASDAQ: AKBA), A ...
Více zde

AKEBIA INITIATES VAFSEO® (VADADUSTAT) POST-MARKETING STUDY IN CONJUNCTION WITH LARGE DIALYSIS ORGANIZATION

04-08-2025
CAMBRIDGE, MASS., AUG. 04, 2025 (GLOBE NEWSWIRE) -- AKEBIA THERAPEUTICS®, INC. (NASDAQ: AKBA), A BI...
Více zde

AKEBIA THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

01-08-2025
CAMBRIDGE, MASS., AUG. 01, 2025 (GLOBE NEWSWIRE) -- AKEBIA THERAPEUTICS®, INC. (NASDAQ: AKBA), A BI...
Více zde

AKEBIA THERAPEUTICS TO REPORT SECOND QUARTER 2025 FINANCIAL RESULTS AND DISCUSS RECENT BUSINESS HIGHLIGHTS

31-07-2025
CAMBRIDGE, MASS., JULY 31, 2025 (GLOBE NEWSWIRE) -- AKEBIA THERAPEUTICS®, INC. (NASDAQ: AKBA) TODAY...
Více zde

AKEBIA THERAPEUTICS TO PRESENT AT THE H.C. WAINWRIGHT 4TH ANNUAL KIDNEY VIRTUAL CONFERENCE

08-07-2025
CAMBRIDGE, MASS., JULY 08, 2025 (GLOBE NEWSWIRE) -- AKEBIA THERAPEUTICS®, INC. (NASDAQ: AKBA), A BI...
Více zde

AKEBIA THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

01-07-2025
CAMBRIDGE, MASS., JULY 01, 2025 (GLOBE NEWSWIRE) -- AKEBIA THERAPEUTICS ® , INC. (NASDAQ: AKBA), A ...
Více zde

VADADUSTAT U.S. PATIENT DATA FROM GLOBAL PHASE 3 CLINICAL PROGRAM PUBLISHED IN JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

04-06-2025
AKEBIA CONTINUES TO PUBLISH IMPORTANT, CLINICALLY RELEVANT DATA TO FURTHER PHYSICIANS' UNDERSTANDING...
Více zde

AKEBIA THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

02-06-2025
CAMBRIDGE, MASS., JUNE 02, 2025 (GLOBE NEWSWIRE) -- AKEBIA THERAPEUTICS®, INC. (NASDAQ: AKBA), A BI...
Více zde

AKEBIA THERAPEUTICS TO PRESENT AT THE JEFFERIES GLOBAL HEALTHCARE CONFERENCE 2025

28-05-2025
CAMBRIDGE, MASS., MAY 28, 2025 (GLOBE NEWSWIRE) -- AKEBIA THERAPEUTICS ® , INC. (NASDAQ: AKBA), A B...
Více zde

AKEBIA THERAPEUTICS ANNOUNCES THREE POSTER PRESENTATIONS AT THE EUROPEAN RENAL ASSOCIATION CONGRESS 2025

27-05-2025
VADADUSTAT CLINICAL DATA ON DISPLAY FOR NEPHROLOGISTS AND HEALTHCARE PROVIDERS VADADUSTAT CLINICAL D...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-30 00:00:008-KStáhnout
2026-01-12 00:00:008-KStáhnout
2025-12-01 00:00:008-KStáhnout
2025-11-17 00:00:008-KStáhnout
2025-11-10 00:00:008-KStáhnout
2025-11-10 00:00:0010-QStáhnout
2025-10-28 00:00:008-KStáhnout
2025-08-07 01:00:008-KStáhnout
2025-08-07 01:00:0010-QStáhnout
2025-08-07 00:00:008-KStáhnout
2025-08-07 00:00:0010-QStáhnout
2025-06-13 01:00:008-KStáhnout
2025-06-13 00:00:008-KStáhnout
2025-05-08 01:00:008-KStáhnout
2025-05-08 01:00:0010-QStáhnout
2025-05-08 00:00:008-KStáhnout
2025-05-08 00:00:0010-QStáhnout
2025-03-20 00:00:008-KStáhnout
2025-03-19 23:00:008-KStáhnout
2025-03-13 00:00:008-KStáhnout
2025-03-13 00:00:0010-KStáhnout
2025-03-12 23:00:008-KStáhnout
2025-03-12 23:00:0010-KStáhnout
2025-02-07 00:00:008-KStáhnout
2025-02-06 23:00:008-KStáhnout
2025-01-13 00:00:008-KStáhnout
2025-01-12 23:00:008-KStáhnout
2024-11-07 00:00:008-KStáhnout
2024-11-07 00:00:0010-QStáhnout
2024-11-06 23:00:008-KStáhnout
2024-11-06 23:00:0010-QStáhnout
2024-10-22 01:00:008-KStáhnout
2024-10-22 00:00:008-KStáhnout
2024-10-16 01:00:008-KStáhnout
2024-10-16 00:00:008-KStáhnout
2024-08-08 01:00:008-KStáhnout
2024-08-08 01:00:0010-QStáhnout
2024-08-08 00:00:008-KStáhnout
2024-08-08 00:00:0010-QStáhnout
2024-07-11 01:00:008-KStáhnout
2024-07-11 00:00:008-KStáhnout
2024-06-24 01:00:008-KStáhnout
2024-06-24 00:00:008-KStáhnout
2024-06-10 01:00:008-KStáhnout
2024-06-10 00:00:008-KStáhnout
2024-05-09 01:00:008-KStáhnout
2024-05-09 01:00:0010-QStáhnout
2024-05-09 00:00:008-KStáhnout
2024-05-09 00:00:0010-QStáhnout
2024-04-23 01:00:008-KStáhnout
2024-04-23 00:00:008-KStáhnout
2024-04-16 01:00:008-KStáhnout
2024-04-16 00:00:008-KStáhnout
2024-03-28 00:00:008-KStáhnout
2024-03-27 23:00:008-KStáhnout
2024-03-15 00:00:008-KStáhnout
2024-03-14 23:00:008-KStáhnout
2024-03-14 00:00:008-KStáhnout
2024-03-14 00:00:0010-KStáhnout
2024-03-13 23:00:008-KStáhnout
2024-03-13 23:00:0010-KStáhnout
2024-02-13 00:00:008-KStáhnout
2024-02-12 23:00:008-KStáhnout
2024-01-30 00:00:008-KStáhnout
2024-01-29 23:00:008-KStáhnout
2024-01-08 00:00:008-KStáhnout
2024-01-07 23:00:008-KStáhnout
2023-12-18 00:00:008-KStáhnout
2023-12-17 23:00:008-KStáhnout
2023-11-21 00:00:008-KStáhnout
2023-11-20 23:00:008-KStáhnout
2023-11-08 00:00:008-KStáhnout
2023-11-08 00:00:0010-QStáhnout
2023-11-07 23:00:008-KStáhnout
2023-11-07 23:00:0010-QStáhnout
2023-11-02 00:00:008-KStáhnout
2023-11-01 23:00:008-KStáhnout
2023-10-25 01:00:008-KStáhnout
2023-10-25 00:00:008-KStáhnout
2023-10-12 01:00:008-KStáhnout
2023-10-12 00:00:008-KStáhnout
2023-09-26 01:00:008-KStáhnout
2023-09-26 00:00:008-KStáhnout
2023-08-28 01:00:0010-QStáhnout
2023-08-28 00:00:0010-QStáhnout
2023-08-25 01:00:008-KStáhnout
2023-08-25 00:00:008-KStáhnout
2023-08-17 01:00:008-KStáhnout
2023-08-17 00:00:008-KStáhnout
2023-08-11 01:00:008-KStáhnout
2023-08-11 00:00:008-KStáhnout
2023-08-01 01:00:008-KStáhnout
2023-08-01 00:00:008-KStáhnout
2023-07-18 01:00:008-KStáhnout
2023-07-18 00:00:008-KStáhnout
2023-06-13 01:00:008-KStáhnout
2023-06-13 00:00:008-KStáhnout
2023-06-08 01:00:008-KStáhnout
2023-06-08 00:00:008-KStáhnout
2023-06-07 01:00:008-KStáhnout
2023-06-07 00:00:008-KStáhnout
2023-06-02 01:00:008-KStáhnout
2023-06-02 00:00:008-KStáhnout
2023-05-31 01:00:008-KStáhnout
2023-05-31 00:00:008-KStáhnout
2023-05-30 01:00:008-KStáhnout
2023-05-30 00:00:008-KStáhnout
2023-05-25 01:00:008-KStáhnout
2023-05-25 00:00:008-KStáhnout
2023-05-23 01:00:008-KStáhnout
2023-05-23 00:00:008-KStáhnout
2023-05-09 01:00:008-KStáhnout
2023-05-09 00:00:008-KStáhnout
2023-05-08 01:00:008-KStáhnout
2023-05-08 01:00:0010-QStáhnout
2023-05-08 00:00:008-KStáhnout
2023-05-08 00:00:0010-QStáhnout
2023-04-28 01:00:008-KStáhnout
2023-04-28 00:00:008-KStáhnout
2023-04-25 01:00:008-KStáhnout
2023-04-25 00:00:008-KStáhnout
2023-04-11 01:00:008-KStáhnout
2023-04-11 00:00:008-KStáhnout
2023-03-10 00:00:0010-KStáhnout
2023-03-09 23:00:0010-KStáhnout
2023-03-09 00:00:008-KStáhnout
2023-03-08 23:00:008-KStáhnout
2023-03-02 00:00:008-KStáhnout
2023-03-01 23:00:008-KStáhnout
2023-02-21 00:00:008-KStáhnout
2023-02-20 23:00:008-KStáhnout
2023-01-09 00:00:008-KStáhnout
2023-01-08 23:00:008-KStáhnout
2022-12-28 00:00:008-KStáhnout
2022-12-27 23:00:008-KStáhnout
2022-12-15 00:00:008-KStáhnout
2022-12-14 23:00:008-KStáhnout
2022-11-10 00:00:008-KStáhnout
2022-11-09 23:00:008-KStáhnout
2022-11-08 00:00:008-KStáhnout
2022-11-07 23:00:008-KStáhnout
2022-11-03 00:00:008-KStáhnout
2022-11-03 00:00:0010-QStáhnout
2022-11-02 23:00:008-KStáhnout
2022-11-02 23:00:0010-QStáhnout
2022-08-04 01:00:008-KStáhnout
2022-08-04 01:00:0010-QStáhnout
2022-08-04 00:00:008-KStáhnout
2022-08-04 00:00:0010-QStáhnout
2022-07-18 01:00:008-KStáhnout
2022-07-18 00:00:008-KStáhnout
2022-06-30 01:00:008-KStáhnout
2022-06-30 00:00:008-KStáhnout
2022-06-10 01:00:008-KStáhnout
2022-06-10 00:00:008-KStáhnout
2022-05-13 01:00:008-KStáhnout
2022-05-13 00:00:008-KStáhnout
2022-05-09 01:00:008-KStáhnout
2022-05-09 01:00:0010-QStáhnout
2022-05-09 00:00:008-KStáhnout
2022-05-09 00:00:0010-QStáhnout
2022-04-07 01:00:008-KStáhnout
2022-04-07 00:00:008-KStáhnout
2022-03-30 01:00:008-KStáhnout
2022-03-30 00:00:008-KStáhnout
2022-03-01 00:00:008-KStáhnout
2022-03-01 00:00:0010-KStáhnout
2022-02-28 23:00:008-KStáhnout
2022-02-28 23:00:0010-KStáhnout
2022-02-22 00:00:008-KStáhnout
2022-02-21 23:00:008-KStáhnout
2022-01-24 00:00:008-KStáhnout
2022-01-23 23:00:008-KStáhnout
2021-11-04 00:00:008-KStáhnout
2021-11-04 00:00:0010-QStáhnout
2021-11-03 23:00:008-KStáhnout
2021-11-03 23:00:0010-QStáhnout
2021-11-01 00:00:008-KStáhnout
2021-10-31 23:00:008-KStáhnout
2021-09-28 01:00:008-KStáhnout
2021-09-28 00:00:008-KStáhnout
2021-09-09 01:00:008-KStáhnout
2021-09-09 00:00:008-KStáhnout
2021-08-24 01:00:008-KStáhnout
2021-08-24 00:00:008-KStáhnout
2021-08-05 01:00:008-KStáhnout
2021-08-05 01:00:0010-QStáhnout
2021-08-05 00:00:008-KStáhnout
2021-08-05 00:00:0010-QStáhnout
2021-06-03 01:00:008-KStáhnout
2021-06-03 00:00:008-KStáhnout
2021-06-01 01:00:008-KStáhnout
2021-06-01 00:00:008-KStáhnout
2021-05-10 01:00:008-KStáhnout
2021-05-10 01:00:0010-QStáhnout
2021-05-10 00:00:008-KStáhnout
2021-05-10 00:00:0010-QStáhnout
2021-03-30 01:00:008-KStáhnout
2021-03-30 00:00:008-KStáhnout
2021-02-25 00:00:008-KStáhnout
2021-02-25 00:00:0010-KStáhnout
2021-02-24 23:00:008-KStáhnout
2021-02-24 23:00:0010-KStáhnout
2021-02-18 00:00:008-KStáhnout
2021-02-17 23:00:008-KStáhnout
2021-02-17 00:00:008-KStáhnout
2021-02-16 23:00:008-KStáhnout
2021-01-28 00:00:008-KStáhnout
2021-01-27 23:00:008-KStáhnout
2021-01-12 00:00:008-KStáhnout
2021-01-11 23:00:008-KStáhnout
2020-12-15 00:00:008-KStáhnout
2020-12-14 23:00:008-KStáhnout
2020-12-02 00:00:008-KStáhnout
2020-12-01 23:00:008-KStáhnout
2020-11-05 00:00:008-KStáhnout
2020-11-05 00:00:0010-QStáhnout
2020-11-04 23:00:008-KStáhnout
2020-11-04 23:00:0010-QStáhnout
2020-09-25 01:00:008-KStáhnout
2020-09-25 00:00:008-KStáhnout
2020-09-11 01:00:008-KStáhnout
2020-09-11 00:00:008-KStáhnout
2020-09-03 01:00:008-KStáhnout
2020-09-03 00:00:008-KStáhnout
2020-08-10 01:00:008-KStáhnout
2020-08-10 01:00:0010-QStáhnout
2020-08-10 00:00:008-KStáhnout
2020-08-10 00:00:0010-QStáhnout
2020-06-18 01:00:008-KStáhnout
2020-06-18 00:00:008-KStáhnout
2020-06-09 01:00:008-KStáhnout
2020-06-09 00:00:008-KStáhnout
2020-05-12 01:00:008-KStáhnout
2020-05-12 00:00:008-KStáhnout
2020-05-05 01:00:008-KStáhnout
2020-05-05 01:00:0010-QStáhnout
2020-05-05 00:00:008-KStáhnout
2020-05-05 00:00:0010-QStáhnout
2020-04-20 01:00:008-KStáhnout
2020-04-20 00:00:008-KStáhnout
2020-04-08 01:00:008-KStáhnout
2020-04-08 00:00:008-KStáhnout
2020-04-07 01:00:008-KStáhnout
2020-04-07 00:00:008-KStáhnout
2020-03-12 00:00:008-KStáhnout
2020-03-12 00:00:0010-KStáhnout
2020-03-11 23:00:008-KStáhnout
2020-03-11 23:00:0010-KStáhnout
2020-03-10 00:00:008-KStáhnout
2020-03-09 23:00:008-KStáhnout
2020-02-18 00:00:008-KStáhnout
2020-02-17 23:00:008-KStáhnout
2019-11-12 00:00:008-KStáhnout
2019-11-12 00:00:0010-QStáhnout
2019-11-11 23:00:008-KStáhnout
2019-11-11 23:00:0010-QStáhnout
2019-09-11 01:00:008-KStáhnout
2019-09-11 00:00:008-KStáhnout
2019-08-08 01:00:008-KStáhnout
2019-08-08 01:00:0010-QStáhnout
2019-08-08 00:00:008-KStáhnout
2019-08-08 00:00:0010-QStáhnout
2019-06-11 01:00:008-KStáhnout
2019-06-11 00:00:008-KStáhnout
2019-06-04 01:00:008-KStáhnout
2019-06-04 00:00:008-KStáhnout
2019-05-09 01:00:008-KStáhnout
2019-05-09 01:00:0010-QStáhnout
2019-05-09 00:00:008-KStáhnout
2019-05-09 00:00:0010-QStáhnout
2019-04-18 01:00:008-KStáhnout
2019-04-18 00:00:008-KStáhnout
2019-04-10 01:00:008-KStáhnout
2019-04-10 00:00:008-KStáhnout
2019-03-26 00:00:0010-KStáhnout
2019-03-25 23:00:0010-KStáhnout
2019-03-18 00:00:008-KStáhnout
2019-03-17 23:00:008-KStáhnout
2019-01-07 00:00:008-KStáhnout
2019-01-06 23:00:008-KStáhnout
2018-12-13 00:00:008-KStáhnout
2018-12-12 23:00:008-KStáhnout
2018-11-16 00:00:008-KStáhnout
2018-11-15 23:00:008-KStáhnout
2018-11-08 00:00:0010-QStáhnout
2018-11-07 23:00:0010-QStáhnout
2018-10-01 01:00:008-KStáhnout
2018-10-01 00:00:008-KStáhnout
2018-08-28 01:00:008-KStáhnout
2018-08-28 00:00:008-KStáhnout
2018-08-08 01:00:0010-QStáhnout
2018-08-08 00:00:0010-QStáhnout
2018-06-28 01:00:008-KStáhnout
2018-06-28 00:00:008-KStáhnout
2018-06-15 01:00:008-KStáhnout
2018-06-15 00:00:008-KStáhnout
2018-05-09 01:00:0010-QStáhnout
2018-05-09 00:00:0010-QStáhnout
2018-04-12 01:00:008-KStáhnout
2018-04-12 00:00:008-KStáhnout
2018-03-26 01:00:008-KStáhnout
2018-03-26 00:00:008-KStáhnout
2018-03-12 00:00:0010-KStáhnout
2018-03-11 23:00:0010-KStáhnout
2017-11-08 00:00:0010-QStáhnout
2017-11-07 23:00:0010-QStáhnout
2017-08-08 01:00:0010-QStáhnout
2017-08-08 00:00:0010-QStáhnout
2017-06-29 01:00:008-KStáhnout
2017-06-29 00:00:008-KStáhnout
2017-06-21 01:00:008-KStáhnout
2017-06-21 00:00:008-KStáhnout
2017-05-25 01:00:008-KStáhnout
2017-05-25 00:00:008-KStáhnout
2017-05-15 01:00:008-KStáhnout
2017-05-15 00:00:008-KStáhnout
2017-05-09 01:00:0010-QStáhnout
2017-05-09 00:00:0010-QStáhnout
2017-04-25 01:00:008-KStáhnout
2017-04-25 00:00:008-KStáhnout
2017-03-06 00:00:0010-KStáhnout
2017-03-05 23:00:0010-KStáhnout
2017-02-13 00:00:008-KStáhnout
2017-02-12 23:00:008-KStáhnout
2016-12-20 00:00:008-KStáhnout
2016-12-19 23:00:008-KStáhnout
2016-11-09 00:00:0010-QStáhnout
2016-11-08 23:00:0010-QStáhnout
2016-09-20 01:00:008-KStáhnout
2016-09-20 00:00:008-KStáhnout
2016-08-08 01:00:0010-QStáhnout
2016-08-08 00:00:0010-QStáhnout
2016-08-02 01:00:008-KStáhnout
2016-08-02 00:00:008-KStáhnout
2016-07-28 01:00:008-KStáhnout
2016-07-28 00:00:008-KStáhnout
2016-06-21 01:00:008-KStáhnout
2016-06-21 00:00:008-KStáhnout
2016-05-05 01:00:0010-QStáhnout
2016-05-05 00:00:0010-QStáhnout
2016-03-14 00:00:0010-KStáhnout
2016-03-13 23:00:0010-KStáhnout
2016-03-09 00:00:008-KStáhnout
2016-03-08 23:00:008-KStáhnout
2016-01-12 00:00:008-KStáhnout
2016-01-11 23:00:008-KStáhnout
2016-01-05 00:00:008-KStáhnout
2016-01-04 23:00:008-KStáhnout
2016-01-04 00:00:008-KStáhnout
2016-01-03 23:00:008-KStáhnout
2015-12-14 00:00:008-KStáhnout
2015-12-13 23:00:008-KStáhnout
2015-11-27 00:00:008-KStáhnout
2015-11-26 23:00:008-KStáhnout
2015-11-09 00:00:0010-QStáhnout
2015-11-08 23:00:0010-QStáhnout
2015-10-06 01:00:008-KStáhnout
2015-10-06 00:00:008-KStáhnout
2015-09-08 01:00:008-KStáhnout
2015-09-08 00:00:008-KStáhnout
2015-08-11 01:00:008-KStáhnout
2015-08-11 01:00:0010-QStáhnout
2015-08-11 00:00:008-KStáhnout
2015-08-11 00:00:0010-QStáhnout
2015-06-15 01:00:008-KStáhnout
2015-06-15 00:00:008-KStáhnout
2015-06-11 01:00:008-KStáhnout
2015-06-11 00:00:008-KStáhnout
2015-05-11 01:00:0010-QStáhnout
2015-05-11 00:00:0010-QStáhnout
2015-04-17 01:00:008-KStáhnout
2015-04-17 00:00:008-KStáhnout
2015-03-04 00:00:0010-KStáhnout
2015-03-03 23:00:0010-KStáhnout
2014-12-18 00:00:008-KStáhnout
2014-12-17 23:00:008-KStáhnout
2014-11-10 00:00:0010-QStáhnout
2014-11-09 23:00:0010-QStáhnout
2014-10-27 00:00:008-KStáhnout
2014-10-26 23:00:008-KStáhnout
2014-09-15 01:00:008-KStáhnout
2014-09-15 00:00:008-KStáhnout
2014-08-11 01:00:0010-QStáhnout
2014-08-11 00:00:0010-QStáhnout
2014-08-06 01:00:008-KStáhnout
2014-08-06 00:00:008-KStáhnout
2014-07-17 01:00:008-KStáhnout
2014-07-17 00:00:008-KStáhnout
2014-05-12 01:00:0010-QStáhnout
2014-05-12 00:00:0010-QStáhnout
2014-03-28 00:00:008-KStáhnout
2014-03-27 23:00:008-KStáhnout
preloader